Abstract
New immunotherapies, also called "immune checkpoints", are promising and showed interesting antitumoral activities in particular in advanced setting of melanoma, clear cell renal cancer or non-small cell lung carcinoma. These treatments include ipilimumab, anti-PD-1 and anti-PD-L1. There is a strong rational for combination of immunotherapies and targeted therapies. This review is dedicated to expose the theorical issues and preclinical data of such combinations. This review examined the impact of immunotherapies on transduction pathways and modification of immunity related to targeted therapies. First clinical data form early drug development studies showed the difficulties observed with such combination and limitating toxicities. Finally, potential interesting combinations are overviewed with an emphasis on sequential treatments.
References
Oct 18, 2005·Molecular and Cellular Biology·Richard V ParryJames L Riley
Dec 13, 2006·Nature Medicine·Andrew T ParsaRussell O Pieper
Dec 17, 2009·The Journal of Experimental Medicine·Loise M FranciscoArlene H Sharpe
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jul 16, 2010·Cancer Research·Rajeev K ShrimaliSteven A Rosenberg
Oct 6, 2010·Cancer·Brian I RiniMichael Gordon
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
May 30, 2012·The Journal of Experimental Medicine·Tadashi YokosukaTakashi Saito
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Aug 2, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jahan S KhaliliGregory Lizée
Oct 26, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaofeng JiangF Stephen Hodi
Oct 31, 2012·Cancer Research·Magali TermeJulien Taieb
Feb 9, 2013·The Journal of Clinical Investigation·Michael HebeisenNathalie Rufer
Feb 28, 2013·Blood·Brian R RosboroughAngus W Thomson
Mar 13, 2013·The Journal of Clinical Investigation·Chen WangJordan S Pober
Apr 5, 2013·The New England Journal of Medicine·Antoni RibasJedd Wolchok
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 6, 2013·Bulletin du cancer·Ecaterina IleanaJean-Charles Soria
Jul 31, 2013·Immunity·Daniel S Chen, Ira Mellman